FDA Import Refusal 799-8303892-8/71/1 — SANDOZ CANADA INC
The FDA refused shipment 799-8303892-8/71/1 from SANDOZ CANADA INC (Canada) on Nov 16, 2023. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Nov 16, 2023
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61PDB70 DAPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75